1252608-59-5 Usage
General Description
GIBH-130 is a synthetic compound that has been developed as a potential treatment for obesity and related metabolic disorders. It acts as a selective agonist for the growth hormone secretagogue receptor, which plays a key role in regulating growth hormone release and energy metabolism. By mimicking the activity of growth hormone-releasing peptides, GIBH-130 has been shown to increase energy expenditure, reduce adiposity, and improve insulin sensitivity in animal studies. These promising results suggest that GIBH-130 may have the potential to be developed into a novel therapeutic agent for addressing the global epidemic of obesity and its related metabolic complications. Further research is needed to fully understand its efficacy and safety in human subjects.
Check Digit Verification of cas no
The CAS Registry Mumber 1252608-59-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,2,6,0 and 8 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1252608-59:
(9*1)+(8*2)+(7*5)+(6*2)+(5*6)+(4*0)+(3*8)+(2*5)+(1*9)=145
145 % 10 = 5
So 1252608-59-5 is a valid CAS Registry Number.
1252608-59-5Relevant articles and documents
AMIDE COMPOUNDS
-
Paragraph 0160-0162; 0166-0168, (2013/09/26)
A compound represented by formula (I) and the pharmaceutical acceptable salt thereof are disclosed, wherein, R1, R2, R3, R4, R5 and Ar are defined as those in the specification.
